Visual functions and adverse ocular effects in patients with amiodarone medication

Acta Ophthalmologica Scandinavica
Kirsi IkäheimoMaija Mäntyjärvi

Abstract

To study visual functions and ocular adverse effects of long-term amiodarone medication. We performed an eye examination of 22 patients with long-term amiodarone medication. In addition to corrected visual acuity, colour vision was studied with the Standard Pseudoisochromatic Plates part 2 and Farnsworth-Munself 100 hue test. Contrast sensitivity was examined with the Pelli-Robson chart. Visual fields were tested by Goldmann and Friedmann perimetry. Two patients with otherwise healthy eyes had abnormal blue colour vision test results. Otherwise colour vision, contrast sensitivity, and visual field test results were within normal range or could be explained by eye diseases such as cataract. Corneal drug deposits were found in 100% of the examined eyes. Slight anterior subcapsular lens opacities were found in 22.2%. Dry eyes were diagnosed in 9.1%. The eye fundi did not reveal any abnormalities that could be thought of as caused by amiodarone. The slight blue colour vision defect found in two patients with otherwise healthy eyes might represent an early sign of the optic nerve impairment which is a rare complication of amiodarone medication. The number of corneal and lens changes as well as dry eyes were found at levels previousl...Continue Reading

References

Jun 24, 1992·JAMA : the Journal of the American Medical Association·A T GosselinkK I Lie
May 1, 1989·Progress in Cardiovascular Diseases·T R VrobelL Rakita
May 1, 1989·Journal of Clinical Pharmacology·N Z KerinM Rubenfire
May 1, 1985·American Heart Journal·E A RaederB Lown
Feb 1, 1987·Acta Ophthalmologica·G R Duff, A G Fraser
Aug 1, 1987·Mayo Clinic Proceedings·L A FeinerF T Fraunfelder
Mar 1, 1987·Archives of Ophthalmology·J W Gittinger, G K Asdourian
Jul 15, 1985·American Journal of Ophthalmology·V C SmithA S Pass
Oct 12, 1973·Documenta Ophthalmologica. Advances in Ophthalmology·E L Greve
May 1, 1970·Vision Research·P R Kinnear
Jun 1, 1983·Acta Ophthalmologica·C E NielsenP Bjerregaard
Oct 1, 1983·Archives of Ophthalmology·A J FlachJ Weddell
Dec 1, 1983·Journal of the American College of Cardiology·H L GreeneG B Trobaugh
May 1, 1982·American Journal of Ophthalmology·G VerriestA Uvijls
Apr 1, 1982·Archives of Ophthalmology·L J Kaplan, W E Cappaert
Oct 1, 1982·The British Journal of Ophthalmology·D V IngramD A Chamberlain
Feb 15, 1995·American Journal of Epidemiology·J A Mares-PerlmanS M Shoff
Oct 1, 1994·Acta Ophthalmologica·J D Thystrup, H C Fledelius
Jan 1, 1993·Documenta Ophthalmologica. Advances in Ophthalmology·A J Flach, B J Dolan
Apr 1, 1997·Acta Ophthalmologica Scandinavica·M MäntyjärviV Honkonen
Mar 11, 1998·Survey of Ophthalmology·M MäntyjärviK Ikäheimo
Sep 23, 2000·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·M A SpeicherG A Chrousos
Nov 15, 2000·Klinische Monatsblätter für Augenheilkunde·D LeifertJ Gerling
Feb 28, 2001·Journal of Cataract and Refractive Surgery·M Mäntyjärvi, T Laitinen

❮ Previous
Next ❯

Citations

Nov 13, 2002·Pharmacoepidemiology and Drug Safety
Nov 4, 2004·Current Opinion in Ophthalmology·David A Hollander, Anthony J Aldave
Dec 29, 2012·Plastic and Reconstructive Surgery·Ufuk AskerogluBahman Guyuron
Apr 30, 2004·Acta Ophthalmologica Scandinavica·M F DominguesF M Falcão-Reis
Jan 28, 2014·Pharmacoepidemiology and Drug Safety·Ana MiguelAltamiro Costa Pereira
Aug 10, 2005·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·A Petzold, G T Plant
Sep 1, 2005·Pediatric Cardiology·S V YildirimK Tokel
Jun 18, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Spyros A PapirisEffrosyni D Manali
Oct 27, 2004·Cornea·Prabashni ReddyKrithika Rajagopalan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Heart, Lung & Circulation
Kiam K Lim, Dorothy J Radford
Klinische Monatsblätter für Augenheilkunde
Dieter SchmidtMartin Schumacher
Seminars in Ophthalmology
David Chen, Thomas R Hedges
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)
A Hobley, J Lawrenson
Archives of Ophthalmology
Frederick W FraunfelderThomas J Mehelas
© 2022 Meta ULC. All rights reserved